Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care?

By Beacon Medical Interchange FEATURING Jack West

10 views

November 2, 2018

Dr. Jack West reviews key results of the PACIFIC trial of the immunotherapy agent durvalumab ...
read more ↘ (Imfinzi) vs. placebo in stage III NSCLC and explains the pros and cons of durvalumab as a new standard of care after concurrent chemoradiation.
↖ read less

0 Comments